Advocacy resources

This statement urges Member States to integrate NCD Alliance prevention and care into primary healthcare and benefit packages, expand access to essential medicines and technologies, strengthen community-based services, use data, and reduce financial barriers.

The WHO resolution on reducing the burden of stroke calls for a stronger and more coordinated global response to stroke prevention, treatment and recovery. It recognises that stroke is now one of the leading causes of death and disability worldwide, with the greatest impact falling on low- and middle-income countries where access to prevention, emergency care and rehabilitation remains limited.

The WHO resolution on steatotic liver disease recognizes the condition as a rapidly growing and under-recognized global health challenge closely linked to obesity, type 2 diabetes, cardiovascular disease and other noncommunicable diseases. It calls on Member States to integrate steatotic liver disease into national NCD strategies, strengthen prevention and early detection through primary healthcare, address shared risk factors, improve surveillance and research, and expand equitable access to care through integrated health system responses.

This statement calls for integrated action on circulatory health, urging Member States to embed cardiovascular disease, diabetes, kidney disease and related NCDs into primary care, UHC packages, prevention, early detection and accountability systems.

This paper sets out a practical policy agenda for change. It argues that countries can accelerate progress by adopting integrated approaches to cardio-renal-metabolic detection and care, Integrated health checks – using a coordinated, life course approach to assessing cardio renal metabolic risks across whole populations offer a powerful opportunity to transform how diabetes, CVD, CKD are detected and managed.

A joint policy brief with the International Society for Pediatric and Adolescent Diabetes (ISPAD) that provides advocates, healthcare professionals and policymakers with recommendations to advance type 1 diabetes screening and early diagnosis.